Gubra AS 2023 AR2
The report highlights Gubra's successful IPO on NASDAQ Copenhagen in March 2023, marking the only biotech IPO in Europe that year. The company achieved record-high organic revenue growth of 29% in its CRO service business, driven by strong demand in obesity and fatty liver disease areas. In its Discovery & Partnerships segment, Gubra signed two new partnerships with Hemab and Boehringer-Ingelheim, and advanced its Amylin anti-obesity asset (GUBamy) into Phase 1 clinical trials. On the ESG front, Gubra conducted its first preliminary double materiality assessment under the ESRS framework and continued its commitment to invest 10% of pre-tax profits into environmental activities through Gubra Green.
Company: Gubra AS
Sector: Health Care
Country: Denmark
Year: 2023
Type: AR2
Pages: 114
Gubra AS
Annual Report
The report highlights Gubra's successful IPO on NASDAQ Copenhagen in March 2023, marking the only biotech IPO in Europe that year. The company achieved record-high organic revenue growth of 29% in its CRO service business, driven by strong demand in obesity and fatty liver disease areas. In its Discovery & Partnerships segment, Gubra signed two new partnerships with Hemab and Boehringer-Ingelheim, and advanced its Amylin anti-obesity asset (GUBamy) into Phase 1 clinical trials. On the ESG front, Gubra conducted its first preliminary double materiality assessment under the ESRS framework and continued its commitment to invest 10% of pre-tax profits into environmental activities through Gubra Green.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees